Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q1- Text added to 2017 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Altor, announced, ASU, biopharma, BioScience, biotechnology, clarify, CNS, collaborate, complexity, content, deferral, Distinguishing, embedded, EMLL, Georgetown, GT, GTP, hundred, indefinite, Medical, motion, myasthenia, narrow, NDA, Neurology, neuropathic, par, partnership, recharacterize, refractory, retroactively, reverse, round, scope, shepherding, Trademark, Translational
Valuein 2017 Q1 filing- Value in 2017 Q2 filing
Original filings
Filing view